Literature DB >> 30833870

Multiple Sclerosis, Anxiety, and Depression in the United Arab Emirates: Does Social Stigma Prevent Treatment?

Nicoline Schiess, Katherine Huether, Kathryn B Holroyd, Faisal Aziz, Essam Emam, Tarek Shahrour, Miklos Szolics, Taoufik Alsaadi.   

Abstract

BACKGROUND: Depression rates in the multiple sclerosis (MS) population in the Arab world have rarely been reported despite people with MS generally having higher rates of depression. We examined depression rates in 416 people with MS versus the general population of Abu Dhabi, United Arab Emirates, and their treatment.
METHODS: A retrospective medical record review of 416 people with MS (age range, 16-80 years) followed up at four large government hospitals in Abu Dhabi was conducted to determine the percentage of people with MS diagnosed as having depression or anxiety.
RESULTS: The depression rate in people with MS (10.8%) was close to that in the general population of Abu Dhabi. The adjusted odds ratios of depression by selected variables showed that there was a significant difference (P = .003) between females and males in reporting depression, with more females reporting depression than males. Greater MS duration was also associated with a higher likelihood of being depressed (P = .025). The anxiety rate in the cohort (4.8%) was lower than that in the general Abu Dhabi population (18.7%).
CONCLUSIONS: The depression rate in people with MS in Abu Dhabi was close to that of the general Abu Dhabi population, but the anxiety rate in people with MS was lower. Explanations for these low rates include possible underreporting by patients and physician factors such as time limitations in busy clinics. Cultural aspects such as strong family support systems and religious factors in this predominantly Muslim population are also possible factors that warrant further investigation.

Entities:  

Keywords:  Anxiety; Depression; Multiple sclerosis (MS); United Arab Emirates

Year:  2019        PMID: 30833870      PMCID: PMC6390819          DOI: 10.7224/1537-2073.2017-041

Source DB:  PubMed          Journal:  Int J MS Care        ISSN: 1537-2073


  25 in total

1.  Major depression in multiple sclerosis: a population-based perspective.

Authors:  S B Patten; C A Beck; J V A Williams; C Barbui; L M Metz
Journal:  Neurology       Date:  2003-12-09       Impact factor: 9.910

2.  The association of depression and anxiety with unhealthy lifestyle among United Arab Emirates adults.

Authors:  H F Moselhy; R Ghubach; O El-Rufaie; T Zoubeidi; P Badrinath; S Sabri; S Yousef
Journal:  Epidemiol Psychiatr Sci       Date:  2012-06       Impact factor: 6.892

3.  The clinical neuropsychiatry of multiple sclerosis.

Authors:  Anthony Feinstein
Journal:  CNS Spectr       Date:  2005-05       Impact factor: 3.790

Review 4.  The prevalence of multiple sclerosis in the Middle East.

Authors:  Jasem Al-Hashel; Aaron D Besterman; Christina Wolfson
Journal:  Neuroepidemiology       Date:  2008-08-21       Impact factor: 3.282

5.  Unrecognised symptoms of depression in a community-based population with multiple sclerosis.

Authors:  C McGuigan; M Hutchinson
Journal:  J Neurol       Date:  2005-09-27       Impact factor: 4.849

6.  Prevalence of multiple sclerosis in Dubai, United Arab Emirates.

Authors:  Jihad Inshasi; Mona Thakre
Journal:  Int J Neurosci       Date:  2011-04-04       Impact factor: 2.292

Review 7.  Psychiatric side effects of interferon-beta in multiple sclerosis.

Authors:  J-L Goeb; C Even; G Nicolas; B Gohier; F Dubas; J B Garré
Journal:  Eur Psychiatry       Date:  2005-12-28       Impact factor: 5.361

8.  Factors influencing quality of life in multiple sclerosis patients: disability, depressive mood, fatigue and sleep quality.

Authors:  I S Lobentanz; S Asenbaum; K Vass; C Sauter; G Klösch; H Kollegger; W Kristoferitsch; J Zeitlhofer
Journal:  Acta Neurol Scand       Date:  2004-07       Impact factor: 3.209

9.  The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R).

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Doreen Koretz; Kathleen R Merikangas; A John Rush; Ellen E Walters; Philip S Wang
Journal:  JAMA       Date:  2003-06-18       Impact factor: 56.272

10.  The retrospective chart review: important methodological considerations.

Authors:  Matt Vassar; Matthew Holzmann
Journal:  J Educ Eval Health Prof       Date:  2013-11-30
View more
  1 in total

Review 1.  A global view of comorbidity in multiple sclerosis: a systematic review with a focus on regional differences, methodology, and clinical implications.

Authors:  Larissa Hauer; Julian Perneczky; Johann Sellner
Journal:  J Neurol       Date:  2020-07-27       Impact factor: 4.849

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.